| 1 |
Selvestrel D, Stocco G, Aloi M, Arrigo S, Cardile S, Cecchin E, Congia M, Curci D, Gatti S, Graziano F, Langefeld CD, Lucafò M, Martelossi S, Martinelli M, Pagarin S, Scarallo L, Stacul EF, Strisciuglio C, Thompson S, Zuin G, Decorti G, Bramuzzo M. DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease. Biomed Pharmacother 2023;157:113901. [PMID: 36462311 DOI: 10.1016/j.biopha.2022.113901] [Reference Citation Analysis]
|
| 2 |
Krauthammer A, Weintraub I, Shaoul R, Lev-Tzion R, Broide E, Wilschanski M, Lerner A, Yerushalmi B, Shouval DS, Shamaly H, Haberman-Ziv Y, Weiss B. Infantile-onset inflammatory bowel disease has variable long-term outcomes. Front Pediatr 2023;11:1097779. [PMID: 36937967 DOI: 10.3389/fped.2023.1097779] [Reference Citation Analysis]
|
| 3 |
Lee H, Jung KB, Kwon O, Son YS, Choi E, Yu WD, Son N, Jeon JH, Jo H, Yang H, Son YR, Yun CS, Cho HS, Kim SK, Kim DS, Park DS, Son MY. Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice. Gut Microbes 2022;14:2121580. [PMID: 36130031 DOI: 10.1080/19490976.2022.2121580] [Reference Citation Analysis]
|
| 4 |
Adriano A, Thompson DM, McMullan C, Price M, Moore D, Booth L, Mathers J. Peer support for carers and patients with inflammatory bowel disease: a systematic review. Syst Rev 2022;11:200. [PMID: 36096828 DOI: 10.1186/s13643-022-02064-6] [Reference Citation Analysis]
|
| 5 |
Chen Y, Chen J, Guo W, Zhang Y, Li J, Xie H, Shen T, Ge Y, Huang Y, Zheng W, Lu M. Clinical Characteristics, In Silico Analysis, and Intervention of Neonatal-Onset Inflammatory Bowel Disease With Combined Immunodeficiency Caused by Novel TTC7A Variants. Front Genet 2022;13:921808. [DOI: 10.3389/fgene.2022.921808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Sinicropi MS, Iacopetta D, Ceramella J, Catalano A, Mariconda A, Pellegrino M, Saturnino C, Longo P, Aquaro S. Triclosan: A Small Molecule with Controversial Roles. Antibiotics 2022;11:735. [DOI: 10.3390/antibiotics11060735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Wlazło M, Kierkuś J. Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature. JCM 2022;11:2004. [DOI: 10.3390/jcm11072004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Feakins R, Torres J, Borralho-Nunes P, Burisch J, Cúrdia Gonçalves T, De Ridder L, Driessen A, Lobatón T, Menchén L, Mookhoek A, Noor N, Svrcek M, Villanacci V, Zidar N, Tripathi M. ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease. J Crohns Colitis 2022;16:343-68. [PMID: 34346490 DOI: 10.1093/ecco-jcc/jjab141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Shanbhag R. Is Early-onset Inflammatory Bowel Disease a Primary Immune Deficiency? Pediatric Infectious Disease 2022;3:125-127. [DOI: 10.5005/jp-journals-10081-1310] [Reference Citation Analysis]
|
| 10 |
Mishra J, Stubbs M, Kuang L, Vara N, Kumar P, Kumar N, Subramanian VS. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/9621668] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 11 |
Morales RA, Rabahi S, Diaz OE, Salloum Y, Kern BC, Westling M, Luo X, Parigi SM, Monasterio G, Das S, Hernández PP, Villablanca EJ. Interleukin-10 regulates goblet cell numbers through Notch signaling in the developing zebrafish intestine. Mucosal Immunol 2022;15:940-51. [PMID: 35840681 DOI: 10.1038/s41385-022-00546-3] [Reference Citation Analysis]
|
| 12 |
Quddusi FI, Youssef MJ, Davis DMR. Dermatologic Manifestations of Systemic Diseases in Childhood. Pediatr Rev 2021;42:655-71. [PMID: 34850179 DOI: 10.1542/pir.2020-000679] [Reference Citation Analysis]
|
| 13 |
Kim ES, Kim D, Yoon Y, Kwon Y, Park S, Kim J, Ahn KM, Ahn S, Choe YH, Kim YJ, Kim MJ. Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity. Front Immunol 2021;12:698721. [PMID: 34456911 DOI: 10.3389/fimmu.2021.698721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Fabiszewska S, Derda E, Szymanska E, Osiecki M, Kierkus J. Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel Diseases. J Clin Med 2021;10:2997. [PMID: 34279480 DOI: 10.3390/jcm10132997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 15 |
Hung HH, Lee HC, Yeung CY, Wang NL, Tang TY, Winter HS, Kelsen JR, Jiang CB. Importance of early detection of infantile inflammatory bowel disease with defective IL-10 pathway: A case report. Medicine (Baltimore) 2021;100:e25868. [PMID: 34032699 DOI: 10.1097/MD.0000000000025868] [Reference Citation Analysis]
|
| 16 |
Krawiec P, Pawłowska-Kamieniak A, Pac-Kożuchowska E. Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson. J Inflamm (Lond) 2021;18:13. [PMID: 33691712 DOI: 10.1186/s12950-021-00279-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Iida C, Tatsumi A, Fujino H, Anzai K, Sumimoto S. Infantile Inflammatory Bowel Disease in a Three-Month-Old-Boy. Cureus 2021;13:e12743. [PMID: 33643722 DOI: 10.7759/cureus.12743] [Reference Citation Analysis]
|
| 18 |
Huang X, Tan SS, Chen Y, Li T. Acquired Rectourethral and Rectovaginal Fistulas in Children: A Systematic Review. Front Pediatr 2021;9:657251. [PMID: 34026691 DOI: 10.3389/fped.2021.657251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Dong F, Xiao F, Ge T, Li X, Xu W, Wu S, Zhang T, Wang Y. Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease. Front Pediatr 2021;9:678390. [PMID: 34113591 DOI: 10.3389/fped.2021.678390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Zhang H, Madi A, Yosef N, Chihara N, Awasthi A, Pot C, Lambden C, Srivastava A, Burkett PR, Nyman J, Christian E, Etminan Y, Lee A, Stroh H, Xia J, Karwacz K, Thakore PI, Acharya N, Schnell A, Wang C, Apetoh L, Rozenblatt-Rosen O, Anderson AC, Regev A, Kuchroo VK. An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets. Cell Rep 2020;33:108433. [PMID: 33238123 DOI: 10.1016/j.celrep.2020.108433] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 21 |
Zhou L, Liu T, Huang B, Luo M, Chen Z, Zhao Z, Wang J, Leung D, Yang X, Chan KW, Liu Y, Xiong L, Chen P, Wang H, Ye L, Liang H, Masters SL, Lew AM, Gong S, Bai F, Yang J, Pui-Wah Lee P, Yang W, Zhang Y, Lau YL, Geng L, Zhang Y, Cui J. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J Allergy Clin Immunol 2021;147:267-79. [PMID: 32941940 DOI: 10.1016/j.jaci.2020.09.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 22 |
Arai K. Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists. Pediatr Gastroenterol Hepatol Nutr 2020;23:411-22. [PMID: 32953636 DOI: 10.5223/pghn.2020.23.5.411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 23 |
Denning NL, Kallis MP, Kvasnovsky CL, Lipskar AM. Outcomes of Initial Subtotal Colectomy for Pediatric Inflammatory Bowel Disease. J Surg Res 2020;255:319-24. [PMID: 32593890 DOI: 10.1016/j.jss.2020.05.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Mahalak KK, Firrman J, Lee JJ, Bittinger K, Nuñez A, Mattei LM, Zhang H, Fett B, Bobokalonov J, Arango-Argoty G, Zhang L, Zhang G, Liu LS. Triclosan has a robust, yet reversible impact on human gut microbial composition in vitro. PLoS One 2020;15:e0234046. [PMID: 32585680 DOI: 10.1371/journal.pone.0234046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 25 |
Parackova Z, Milota T, Vrabcova P, Smetanova J, Svaton M, Freiberger T, Kanderova V, Sediva A. Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn's disease. Cell Death Dis 2020;11:430. [PMID: 32514016 DOI: 10.1038/s41419-020-2652-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Tang Z, Huang Z, Yan W, Zhang Y, Shi P, Dong K, Gong Y, Ji M, Wang Y, Yu Z, Huang Y. Complications of enterostomy and related risk factor analysis of very early onset inflammatory bowel disease with interleukin-10 signalling deficiency: a single-centre retrospective analysis. BMC Gastroenterol 2020;20:8. [PMID: 31931724 DOI: 10.1186/s12876-020-1160-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 27 |
Rezaei N, de Vries E, Gambineri E, Meyts I, Haddad E. Common presentations and diagnostic approaches. Stiehm's Immune Deficiencies 2020. [DOI: 10.1016/b978-0-12-816768-7.00001-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
